NCT06931457 Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet Rich Plasma to Treat Idiopathic Glossopharyngeal Neuralgia (GPN)
| NCT ID | NCT06931457 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Tiantan Hospital |
| Condition | Glossopharyngeal Neuralgia |
| Study Type | OBSERVATIONAL |
| Enrollment | 121 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2027-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 121 participants in total. It began in 2025-05-01 with a primary completion date of 2027-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the efficacy and safety of the application of PRF combined PRP to the for the treatment of GPN.
Eligibility Criteria
Inclusion Criteria: 1. age \>18 years; 2. diagnosed with idiopathic GPN according to the third International Classification of Headache Disorders (ICHD) classification; 3. patients who failed pharmacotherapy or intolerable side effects of medication; 4. undergoing PRF for GPN; 5. at least 1 month of follow-up recordings. Exclusion Criteria: 1. Patients with bilateral GPN; 2. Abnormalities in blood measurements, liver and kidney function, blood glucose, coagulation, electrocardiography or chest radiography; 3. Infection at the puncture site; 4. Previous mental illness; 5. Previous history of narcotic drug abuse; 6. Prior anticoagulant or antiplatelet therapy; 7. An implantable pulse generator; 8. Current pregnancy or breast feeding. 9. Patients with incomplete medical records (lack of baseline data or postoperative follow-up data).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06931457 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Glossopharyngeal Neuralgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06931457 currently recruiting?
Yes, NCT06931457 is actively recruiting participants. Contact the research team at 13611326978@163.com for enrollment information.
Where is the NCT06931457 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06931457 clinical trial?
NCT06931457 is sponsored by Beijing Tiantan Hospital. The trial plans to enroll 121 participants.